Incidence of valganciclovir-related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease.

Sara BelgaCristina HernandezDima Kabbani Carlos Cervera

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2024)

VGCV prophylaxis is limited by high rates of neutropenia. Future prospective studies are needed to assess alternative CMV prophylactic strategies in SOT recipients.

Keyphrases

current status
kidney transplantation
case control
drug induced